{"id":46060,"date":"2023-03-16T05:45:11","date_gmt":"2023-03-16T05:45:11","guid":{"rendered":"https:\/\/dailytalks.org\/?p=46060"},"modified":"2023-03-16T05:45:11","modified_gmt":"2023-03-16T05:45:11","slug":"europe-liver-cancer-therapeutics-market-is-at-the-cusp-of-crossing-cagr-of-8-95-n-2023-2030","status":"publish","type":"post","link":"https:\/\/dailytalks.org\/?p=46060","title":{"rendered":"Europe Liver Cancer Therapeutics Market Is at the Cusp of Crossing CAGR of 8.95% N 2023-2030"},"content":{"rendered":"<p>Global Europe Liver Cancer Therapeutics Market to Witness Huge Growth by Key Players: Amgen Inc., AstraZeneca PLC, Bayer AG, Celgene Corporation, Eli Lilly, Bristol-Myers Squibb Company, Gilead Sciences, Inc., Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company, Limited, and UCB SA. among others.Hyderabad, Telengana &#8212; (SBWIRE) &#8212; 02\/08\/2023 &#8212;  The Europe liver cancer therapeutics market is projected to grow in the coming years&#8230;<br \/><a href=\"http:\/\/www.sbwire.com\/press-releases\/europe-liver-cancer-therapeutics-market-is-at-the-cusp-of-crossing-cagr-of-895-n-2023-2030-1370243.htm\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Global Europe Liver Cancer Therapeutics Market to Witness Huge Growth by Key Players: Amgen Inc.,<\/p>\n","protected":false},"author":1,"featured_media":46061,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[],"class_list":["post-46060","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-europe"],"featured_image_urls":{"full":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/03\/46060-europe-liver-cancer-therapeutics-market-is-at-the-cusp-of-crossing-cagr-of-8-95-n-2023-2030.jpg",108,55,false],"thumbnail":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/03\/46060-europe-liver-cancer-therapeutics-market-is-at-the-cusp-of-crossing-cagr-of-8-95-n-2023-2030.jpg",108,55,false],"medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/03\/46060-europe-liver-cancer-therapeutics-market-is-at-the-cusp-of-crossing-cagr-of-8-95-n-2023-2030.jpg",108,55,false],"medium_large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/03\/46060-europe-liver-cancer-therapeutics-market-is-at-the-cusp-of-crossing-cagr-of-8-95-n-2023-2030.jpg",108,55,false],"large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/03\/46060-europe-liver-cancer-therapeutics-market-is-at-the-cusp-of-crossing-cagr-of-8-95-n-2023-2030.jpg",108,55,false],"1536x1536":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/03\/46060-europe-liver-cancer-therapeutics-market-is-at-the-cusp-of-crossing-cagr-of-8-95-n-2023-2030.jpg",108,55,false],"2048x2048":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/03\/46060-europe-liver-cancer-therapeutics-market-is-at-the-cusp-of-crossing-cagr-of-8-95-n-2023-2030.jpg",108,55,false],"chromenews-featured":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/03\/46060-europe-liver-cancer-therapeutics-market-is-at-the-cusp-of-crossing-cagr-of-8-95-n-2023-2030.jpg",108,55,false],"chromenews-large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/03\/46060-europe-liver-cancer-therapeutics-market-is-at-the-cusp-of-crossing-cagr-of-8-95-n-2023-2030.jpg",108,55,false],"chromenews-medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/03\/46060-europe-liver-cancer-therapeutics-market-is-at-the-cusp-of-crossing-cagr-of-8-95-n-2023-2030.jpg",108,55,false]},"author_info":{"display_name":"Jonathan Jeriah","author_link":"https:\/\/dailytalks.org\/?author=1"},"category_info":"<a href=\"https:\/\/dailytalks.org\/?cat=16\" rel=\"category\">Europe<\/a>","tag_info":"Europe","comment_count":"0","_links":{"self":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/46060","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=46060"}],"version-history":[{"count":0,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/46060\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/media\/46061"}],"wp:attachment":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=46060"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=46060"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=46060"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}